A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Helmsley Charitable Trust Grants $4.7m to Fund Life-Saving Technology to Confront Cardiac Threat from COVID-19

Helmsley Charitable Trust reports $4,711,481 in funding will be distributed across five upper-midwestern states to pay for 367 LUCAS mechanical CPR devices to be deployed to hospitals caring for patients during the pandemic and beyond.

“These devices are vital because we don’t want frontline healthcare workers to choose between trying to save a patient or risking exposure to themselves and others to the Coronavirus,” said Walter Panzirer, a trustee for the Helmsley Charitable Trust. “LUCAS has been a proven, effective tool in saving lives during cardiac arrest, and having more of them available during this pandemic will save even more lives, including those of the doctors, nurses and other healthcare workers.”

Research has shown cardiac damage in as many as 1 in 5 COVID-19 patients, leading to heart failure and death even among those who show no signs of respiratory distress. Among patients who recover, many could have long-term effects from such heart damage.

The rise in cardiac complications caused by COVID-19 exposes both patients and healthcare workers to greater risk, as hands-on CPR can be needed for extended periods. Mechanical CPR has been adopted by emergency medical responders and many hospitals around the globe.

The Helmsley Charitable Trust is partnering with medical facilities in South Dakota, North Dakota, Montana, Wyoming, and Nebraska to ensure the devices are in place before the peak of COVID-19 hits. The devices will remain in place after the pandemic as part of the hospitals’ cardiac system of care.

“We were able to go from concept to delivery of the devices in two weeks, and that’s been an incredible effort of teamwork with the manufacturer and the hospitals,” said Panzirer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy